Vaxxa Past Earnings Performance
Past criteria checks 0/6
Vaxxa's earnings have been declining at an average annual rate of -39.7%, while the Entertainment industry saw earnings growing at 36.5% annually. Revenues have been growing at an average rate of 69.7% per year.
Key information
-39.7%
Earnings growth rate
51.8%
EPS growth rate
| Entertainment Industry Growth | 38.5% |
| Revenue growth rate | 69.7% |
| Return on equity | -18.1% |
| Net Margin | -3.1% |
| Next Earnings Update | 03 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Vaxxa makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 70 | -2 | 6 | 0 |
| 31 Dec 23 | 55 | -5 | 5 | 0 |
| 30 Sep 23 | 41 | -42 | 4 | 0 |
| 30 Jun 23 | 44 | -48 | 4 | 0 |
| 31 Mar 23 | 47 | -51 | 5 | 0 |
| 31 Dec 22 | 46 | -51 | 5 | 0 |
| 30 Sep 22 | 32 | -22 | 5 | 0 |
| 30 Jun 22 | 21 | -17 | 5 | 0 |
| 31 Mar 22 | 9 | -14 | 5 | 0 |
| 31 Dec 21 | 5 | -13 | 6 | 0 |
| 30 Sep 21 | 4 | -7 | 5 | 0 |
| 30 Jun 21 | 3 | -8 | 6 | 0 |
| 31 Mar 21 | 1 | -7 | 5 | 0 |
| 31 Dec 20 | 1 | -6 | 4 | 0 |
| 30 Sep 20 | 1 | -5 | 4 | 0 |
| 30 Jun 20 | 1 | -4 | 3 | 0 |
| 31 Mar 20 | 1 | -5 | 3 | 0 |
| 31 Dec 19 | 1 | -5 | 3 | 0 |
| 30 Sep 19 | 1 | -6 | 3 | 0 |
| 30 Jun 19 | 2 | -5 | 3 | 0 |
| 31 Mar 19 | 2 | -5 | 3 | 0 |
| 31 Dec 18 | 3 | -4 | 3 | 0 |
| 30 Sep 18 | 3 | -4 | 3 | 0 |
| 30 Jun 18 | 4 | -4 | 3 | 0 |
| 31 Mar 18 | 4 | -4 | 3 | 0 |
| 31 Dec 17 | 4 | -4 | 4 | 0 |
| 30 Sep 17 | 4 | -3 | 3 | 0 |
| 31 Dec 16 | 1 | -1 | 2 | 0 |
Quality Earnings: VAXXA is currently unprofitable.
Growing Profit Margin: VAXXA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VAXXA is unprofitable, and losses have increased over the past 5 years at a rate of 39.7% per year.
Accelerating Growth: Unable to compare VAXXA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VAXXA is unprofitable, making it difficult to compare its past year earnings growth to the Entertainment industry (-19.6%).
Return on Equity
High ROE: VAXXA has a negative Return on Equity (-18.07%), as it is currently unprofitable.